
Next-generation mRNA medicines
The team at ParcelBio is searching for a highly motivated, intellectually curious scientist to help us develop next-generation mRNA medicines. In this role, you will work closely with our founding team to design, produce, and characterize an entirely new class of mRNA therapeutics. Your responsibilities will include generating mRNA for large-scale applications and screening campaigns, assay/method development, and collaborating with an interdisciplinary team to advance programs to the clinic. The ideal candidate brings a strong foundation in nucleic acid molecular biology and is energized by innovation and scientific excellence.
Lead RNA research and development projects involving mRNA production and characterization, including:
ParcelBio is a next-generation mRNA therapeutics company developing the most potent and durable mRNA medicines. The company’s lead program is a potentially first-in-class, multi-targeted in vivo CAR-T cell therapy designed to treat dozens of autoimmune disorders, with plans to enter the clinic in 2027. Founded by experts in RNA medicines and backed by prominent investors, ParcelBio is pushing the frontier of what’s possible with mRNA medicines.